OTC · HSTC
HST Global, Inc.
$0.70$0.00 (0.0%)
HST Global, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
Loading market information…
OTC · ALST · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
AllStar Health Brands Inc’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AllStar Health Brands Inc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Allstar Health Brands, Inc., a specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas. The company holds the Tapout license to sell globally branded nutraceutical products, including pain relief sprays and wipes. It has partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products. Allstar Health Brands, Inc. was formerly known as Axxess Pharma, Inc. and changed its name to Allstar Health Brands, Inc. in June 2017. The company was founded in 1997 and is headquartered in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:10 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.70$0.00 (0.0%)
HST Global, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
€0.71-€0.03 (-4.59%)
Theraclion S.A.’s quoted price sits in the upper half of its reported 52-week range, 24.09% below the high.
$0.00$0.00 (0.0%)
VIA Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Neurogenesis, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
ChromoCure, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
Accelera Innovations, Inc: Healthcare · Medical - Healthcare Information Services.
$0.00$0.00 (0.0%)
Winston Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
Acutus Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.29% below the high.
